Sagimet Biosciences announced that its oral fatty acid synthase inhibitor, denifanstat, successfully met all primary and secondary endpoints in a Phase 3 clinical trial for treating moderate to ...

The Chinese study saw 480 patients with moderate to severe acne vulgaris receive either a once-daily 50-mg dose of the oral fatty acid synthase inhibitor denifanstat or placebo for 12 weeks.

About BJT-188 BJT-188 is a preclinical, liver-targeted fatty acid synthase (FASN) inhibitor currently under investigation by Bluejay Therapeutics for the treatment of metabolic dysfunction-associated ...

About BJT-188 BJT-188 is a preclinical, liver-targeted fatty acid synthase (FASN) inhibitor currently under investigation by Bluejay Therapeutics for the treatment of metabolic dysfunction ...

About BJT-188 BJT-188 is a preclinical, liver-targeted fatty acid synthase (FASN) inhibitor currently under investigation by Bluejay Therapeutics for the treatment of metabolic dysfunction-associated ...

Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases ...

Fatty acid synthase inhibition to prevent metastatic colonization by pancreatic neuroendocrine tumor cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting ...

Sagimet Biosciences Inc. (NASDAQ:SGMT) is a clinical-stage biopharmaceutical company that creates drugs called fatty acid synthase inhibitors.

Number of Hedge Fund Holders: 18 Sagimet Biosciences Inc. (NASDAQ:SGMT) is a clinical-stage biopharmaceutical company that creates drugs called fatty acid synthase inhibitors.

Sagimet Biosciences Inc. (NASDAQ:SGMT) is a clinical-stage biopharmaceutical company that creates drugs called fatty acid synthase inhibitors. These drugs aim to treat diseases caused by problems ...

Fatty acid synthase, the enzyme responsible for fatty acid production in cells, may be a therapeutic target for IPF, a mouse study found.